Life Spine Announces FDA 510(k) Clearance for the ProLift® Micro Expandable Spacer System

Wednesday, October 13, 2021

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the ProLift micro Expandable Spacer System.

ProLift micro is uniquely designed to support Micro Invasive procedures ranging from endoscopic TLIFs to MIS TLIFs/PLIFs. ProLift micro features an 8mm width, self-locking expansion at any height (8mm to 16mm) to suit the patient's individual pathology and anatomical conditions. In addition, ProLift micro is available in a range of sizes and footprints.

"ProLift micro is designed for a fully percutaneous fusion via an endoscopic approach. The procedure, which is being developed for next year, consists of fully integrated augmented reality (AR) and 3D imaging. The AR vision system allows the surgeon to view live endoscopic 3D video, interactive product images and pre-op/real time radiographs," said Rich Mueller, Chief Operating Officer for Life Spine.

ProLift micro marks the company's 14th expandable interbody device making it one of the largest and most innovative portfolios within the spine fusion market.

ProLift micro Features and Benefits:

  • Post-packable & Repositionable, in situ
  • Osseo-Loc® Surface Technology
  • Intuitive instrumentation that helps protect neural anatomy
  • 0˚, 7˚, 12˚, & 15˚ Lordosis
  • Augmented Reality Assisted Fusions – coming next year
Latest Issue
Get instant
access to our latest e-book